Biosimilar Antibody

Items 726-750 of 840

Name Type Reactivity PDF Catalog Nr.
Teplizumab (Biosimilar Reference Antibody) (CD3E) OURS-RA0106
Teprotumumab (Biosimilar Reference Antibody) (IGF1R) OURS-RA0322
Teropavimab (Biosimilar Reference Antibody) (HIV-1 gp120 CD4bs) OURS-RA0294
Tesidolumab (Biosimilar Reference Antibody) (C5) OURS-RA0053
Tesnatilimab (Biosimilar Reference Antibody) (KLRK1) OURS-RA0451
Tezepelumab (Biosimilar Reference Antibody) (TSLP) OURS-RA0804
Tifcemalimab (Biosimilar Reference Antibody) (BTLA) OURS-RA0040
Tigatuzumab (Biosimilar Reference Antibody) (TNFRSF10B) OURS-RA0754
Tilavonemab (Biosimilar Reference Antibody) (MAPT) OURS-RA0479
Tildrakizumab (Biosimilar Reference Antibody) (IL23A) OURS-RA0370
Tilogotamab (Biosimilar Reference Antibody) (TNFRSF10B) OURS-RA0755
Tilvestamab (Biosimilar Reference Antibody) (AXL) OURS-RA0033
Timcevibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD) OURS-RA0667
Timigutuzumab (Biosimilar Reference Antibody) (ERBB2) OURS-RA0228
Timolumab (Biosimilar Reference Antibody) (AOC3) OURS-RA0017
Tinurilimab (Biosimilar Reference Antibody) (CEACAM6) OURS-RA0140
Tiragolumab (Biosimilar Reference Antibody) (TIGIT) OURS-RA0738
Tirnovetmab (Biosimilar Reference Antibody) (IL31 (Canine)) OURS-RA0379
Tislelizumab (Biosimilar Reference Antibody) (PDCD1) OURS-RA0586
Tisotumab (Biosimilar Reference Antibody) (F3) OURS-RA0241
Tixagevimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD) OURS-RA0668
Tobevibart (Biosimilar Reference Antibody) (Human Papillomavirus Envelope Protein) OURS-RA0298
Tocilizumab (Biosimilar Reference Antibody) (IL6R) OURS-RA0408
Tomaralimab (Biosimilar Reference Antibody) (TLR2) OURS-RA0740
Tomuzotuximab (Biosimilar Reference Antibody) (EGFR) OURS-RA0209

Items 726-750 of 840